The content on this site is intended for healthcare professionals only
Goals of the International Cancer Microbiome Consortium
What to expect from a PET scan
The difficulties of working with radiotracers
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Patient empowerment and quality of life
Nivolumab and ipilimumab for metastatic kidney cancer
The role of tumour marker testing in early diagnosis
The METRIC trial of trametinib, five years on
Patient perceptions of chemotherapy side effects differ over time and treatment
Treatment choices in thyroid cancer
New strategies in melanoma care
RANGE trial of ramucirumab for urothelial cancer
